Enova counsel exercises options, sells 12,879 shares
Enova International’s General Counsel and Secretary, Sean Rahilly, reported an option exercise and share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Enova International’s General Counsel and Secretary, Sean Rahilly, reported an option exercise and share sale. On 01/30/2026, he exercised 12,879 non-qualified stock options at an exercise price of $20.73 per share, receiving 12,879 common shares.
That same day, he sold 12,879 common shares at a weighted average price of $164.2821, from multiple trades between $163.415 and $164.95. After these transactions, he directly held 100,877 shares of common stock and 15,000 non-qualified stock options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 12,879 | $0.00 | $0.00 |
| Exercise | Common stock, par value $0.00001 per share | 12,879 | $20.73 | $267K |
| Sale | Common stock, par value $0.00001 per share | 12,879 | $164.2821 | $2.12M |
Footnotes (4)
- F1. This transaction was executed in multiple trades at prices ranging from $163.415 to $164.95. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
- F2. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F3. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F4. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022 and February 11, 2023.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Enova International (ENVA) report for Sean Rahilly?
What stock options did Enova’s Sean Rahilly exercise in this Form 4 filing?
What is the limited stock appreciation right (SAR) mentioned in Enova’s Form 4?
What does the Form 4 say about how Enova (ENVA) sale prices were calculated?
AI-generated analysis. How Rhea-AI works. Not financial advice.